In the patient cohort included in this study, we found a non-significant (p = 0.063) trend towards a decrease in the CSF/serum albumin ratio for the AD subjects (5.8 ± 0.6) compared to NADC (7.4 ± 0.6). Here, ALB is linked to Alzheimer disease.